CUE
Cue Biopharma, Inc.
Key Financials
Net Income
$-26602000
↑ 34.6%
Operating Income
$-26552000
↑ 36.0%
Revenue
$27.5M
↑ 195.7%
Total Assets
$42.2M
↑ 31.1%
Total Liabilities
$15.8M
↑ 7.4%
Cash & Equivalents
$27.1M
↑ 20.8%
EPS (Diluted)
$-0.28
↑ 61.1%
Shareholders' Equity
$26.4M
↑ 51.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 3 | 6/11/2026 | View on SEC |
| 3 | 6/11/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 3 | 6/8/2026 | View on SEC |
| 4 | 6/3/2026 | View on SEC |
| 8-K | 6/3/2026 | View on SEC |
| S-8 | 6/3/2026 | View on SEC |
| S-3 | 6/3/2026 | View on SEC |
| 4 | 6/2/2026 | View on SEC |
| 3 | 6/2/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CUE |
| Company Name | Cue Biopharma, Inc. |
| CIK | 1645460 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-949-2680 |